Relora with Bacopa
En vente sur le marché américain (selon le DSLD)
DaVinci Laboratories, food supplement from the US market
Relora with Bacopa (DaVinci Laboratories), a food supplement au code-barres 026664298065, is described by its US market label, recorded on 14 December 2023. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.
Official label, entered on 14 December 2023. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
No point flagged by the rules we apply.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- DaVinci Laboratories
- Barcode
- 026664298065
- Form
- Capsule
- One serving
- 1 capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Cellulose, Microcrystalline Cellulose, Leucine
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Relora | Blend | 375 mg |
| Magnolia officinalis Bark Extract | Plant | not stated |
| Phellodendron amurense bark extract | Plant | not stated |
| Bacopa monnieri leaf extract (Bacopa monnieri) | Plant | 100 mg |
| Bacosides | Other substance | 20 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Relora with Bacopa
Entered into DSLD on 18 July 2023. Retirée du marché américain le 1 October 2022 (selon le DSLD).- Same quantity, different name: Bacosides A & B in this version; Bacosides on the displayed label (20 mg)
Official label: Relora With Bacopa
Entered into DSLD on 25 July 2013. Retirée du marché américain le 17 August 2022 (selon le DSLD).- Active ingredient removed : Magnolia officinalis Bark Extract (quantity not stated)
- Active ingredient removed : Phellodendron amurense bark extract (quantity not stated)
- Same quantity, different name: Bacopa Monnieri Extract in this version; Bacopa monnieri leaf extract on the displayed label (100 mg)
- Same quantity, different name: Bacosides A & B in this version; Bacosides on the displayed label (20 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : DaVinci Laboratories